Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols

Protocols

EDRN investigators protocols. The following is a list of the EDRN protocols that have been captured and curated. Additional information will be added as it is available. Contact information is provided as part of the detail for each protocol.

Contents

Title Abstract Investigator
Biomarker Detection Using NAPPA Tumor Antigen Arrays: EDRN Supplement The overall goal of this project application for the EDRN set-aside funds is to focus our collaborative efforts to identify p53 mutation-specific antibody ... Anderson, Karen
Biomarker Dev Lab At Moffitt Supplement Tockman, Melvyn S.
Biomarker Development Laboratory Zhao, Yingming
Biomarker Discovery for Renal Cell Carcinoma Through Serum, Urine and Tissue Protein Profiles Basler, Joseph W.
Biomarker Reference Sets for Cancers in Women The purpose of this study is to develop a standard reference set of specimens for use by investigators participating in the National Cancer Institutes Early ... Cramer, Daniel
Biomarkers and clinical parameters associated with Gleason score upgrading Thompson, Ian M.
Biomarkers for Prostate and Bladder Cancer CD26+ cancer cells and CD90+ tumor-associated stromal cells were sorted from tumor tissue. Dataset analysis with transcriptomes of CD26+ luminal, CD104+ basal, ... Liu, Alvin Y.
Biomarkers for early detection of pancreatic cancer Background: The clinical management of pancreatic cancer is severely hampered by the absence of effective screening tools. Methods: Sixty-seven biomarkers ... Lokshin, Anna
Biomarkers for the Early Detection of Pancreatic Cancer Killary, Ann M.
Biomarkers in Familial Multiple Myeloma Lynch, Henry
Biomarkers of Risk for Colorectal Neoplasia (Team Project #2) The goal of this project is to evaluate biomarkers in normal colonic mucosa to determine their relationship to the occurrence of short- and long-term ... Schoen, Robert E.
Biomarkers to Distinguish Aggressive Cancers from Non-aggressive or Non- progressing cancers We hypothesize that our novel Biomarker Panel of Auto-antibodies can distinguish aggressive, symptom diagnosed lung cancer from non-aggressive, screen-detected ... Rom, William
Biomarkers to Distinguish Aggressive Cancers from Non-aggressive or Non-progressing Cancer Distinguishing aggressive cancers from non-aggressive or non-progressing cancers is an issue of both clinical and public health importance particularly for ... Li, Christopher
Body Fluids as a Source of Diagnostic Biomarkers Semmes, John
Body Fluids as a Source of Diagnostic Biomarkers: Breast Semmes, John
Body Fluids as a Source of Diagnostic Biomarkers: Prostate Recent advances in high-throughput protein expression profiling of bodily fluids has generated great enthusiasm and hope for this approach as a potent ... Semmes, John
Breast Cancer: subgroups specific blood-biomarkers for early / predictive diagnosis and personalized treatment Breast-conserving lumpectomy followed by radiation therapy has been shown to be an alternative strategy, competitive to mastectomy, in preventing mortality ... Golubnitschaja, Prof. Dr. Olga
Breast Ductal Lavage Fluid Specimen Bank Trock, Bruce
Breast Ref Applicant: Abbott-Arkansas Medical Sciences (2013) We are evaluating whether detection of a tumor-specific N-linked glycosylation known as B 1,6 branched N-glycan present on the glycoprotein periostin in breast ... Abbott, Karen
Breast Ref Applicant: Anderson-Arizona (2014) The aims of the proposal are to evaluate this panel of 28 AAb biomarkers using the EDRN reference set. We propose to use RAPID ELISA containing each of these ... Anderson, Karen
Breast Ref Applicant: Chris Li (2014) Li, Christopher
Breast Ref Applicant: Mukherjee 2014 Mukherhjee, Pinku
Breast Ref Set Applicant: Anu Mathew-Meso Scale (2012) Mathew, Anu
Breast Reference Set Application: Anu Mathew-Meso Scale (2012) Using a subset of plasma samples (n=505) from the reference set, we analyzed 90 proteins by multiplexed immunoassays for their potential utility as diagnostic ... Mathew, Anu
Breast Reference Set Application: Chris Li-FHCRC (2014) This application proposes to use Reference Set #1. We request access to serum samples collected at the time of breast biopsy from subjects with IC (n=30) or ... Li, Christopher
Breast Reference Set Application: Chris Li-FHCRC (2015) Li, Christopher
Breast Reference Set Application: GeorgeTuszynski-Temple (2012) As recommended by the review committee, we will analyze 30 invasive cancer cases and 30 benign controls from the EDRN breast reference set. Cases and controls ... Tuszynski, George
Breast Reference Set Application: Karen Abbott- University of Arkansas (2013) We are evaluating whether detection of a tumor-specific N-linked glycosylation known as B 1,6 branched N-glycan present on the glycoprotein periostin in breast ... Abbott, Karen
Breast Reference Set Application: Karen Anderson-ASU (2014) In order to increase the predictive value of tumor-specific antibodies for use as immunodiagnostics, our EDRN BDL has developed a novel protein microarray ... Anderson, Karen
Breast Reference Set Application: Pinku Mukherjee-CanDiag (2014) We would like to get all three sets of specimens, however, we are requesting Specimen Set 1 first: 30 subjects with invasive cancer and 30 subjects with benign ... Mukherhjee, Pinku
2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.

Announcement